A monthly video conference series about how you and LLS are advancing blood cancer research in the quest for cures.
With hosts Drs. Lou DeGennaro, Gwen Nichols and Lee Greenberger
LLS's Venture Philanthropy Model for Accelerating Promising Therapies
October 20 at 12:30PM (ET)
Through the Therapy Acceleration Program (TAP), LLS partners with visionaries in the biotechnology industry to accelerate promising research through “the valley of death,” where new discoveries are often stalled on their way to the clinic. Through our venture philanthropy model, LLS invests in high impact research to realize innovative new therapies for patients. For this conversation, LLS welcomes a panel of our TAP biotech partners and industry leaders to discuss the power of this model for driving novel approaches to cancer treatment.
David Chang, MD, PhD (Allogene Therapeutics, Inc.) is co-founder, President and CEO of Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor (CAR) T cell therapies for cancer. Dr. Chang led the development of CAR T-cell therapy at KITE pharmaceuticals which, with LLS’s investment, achieved the first FDA approval for this revolutionary immunotherapy.
Jolanta Grembecka, PhD (University of Michigan), started developing molecules targeting mixed-lineage leukemias through an LLS grant awarded in 2009, which led to two further grants for the research. This ultimately led to a TAP project in partnership with Kura Oncology, demonstrating the powerful trajectory of LLS grants funding.
Jared Gollob, MD (Kymera Therapeutics), is Chief Medical Officer of Kymera Therapeutics, a biotech company pioneering an emerging approach to cancer therapy called “targeted protein degradation” which harnesses for cancer therapy the body’s natural system of ridding itself of unwanted, ‘old’ or ‘broken’ components of cells.
November (date TBD): Prevention & Survivorship Program
September 2020: The Remarkable Promise of Immunotherapy (video recording here)
August 2020: Research at the Intersection of COVID-19 and Blood Cancer (video recording here)
July 2020: A Panel Discussion on the Career Development Program (video recording here)